Information  X 
Enter a valid email address

Blend Funding PLC (51NF)

  Print      Mail a friend

Thursday 14 March, 2019

Blend Funding PLC

Publication of Supplement to Pricing Supplement

RNS Number : 9498S
Blend Funding PLC
14 March 2019
 

 

NOT FOR DISTRIBUTION TO ANY U.S. PERSON OR TO ANY PERSON OR ADDRESS IN THE U.S.

 

bLEND Funding Plc

 

£50,000,000 2.984 per cent. Secured Notes due 2034/2036

(ISIN: XS1963482390)

(the Notes)

 

issued under the £2,000,000,000 Secured Euro Medium Term Note Programme

(the Programme)

 

bLEND Funding Plc is pleased to confirm that the following Supplement dated 14th March, 2019 (the Supplement) to the Pricing Supplement dated 13th March, 2019 (the Pricing Supplement), issued under its £2,000,000,000 Secured Euro Medium Term Note Programme, is available for viewing:

 

Supplement to the Pricing Supplement for the issue of £50,000,000 2.984 per cent. Secured Notes due 2034/2036

 

To view the Supplement, please paste the following URL into the address bar of your browser:

 

http://www.rns-pdf.londonstockexchange.com/rns/9498S_1-2019-3-14.pdf

 

For further information please contact Piers Williamson or Fenella Edge on 020 7337 9920.

 

bLEND Funding Plc is a wholly owned subsidiary of The Housing Finance Corporation Limited.

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in the Supplement may be addressed to and/or targeted at persons who are residents of particular countries (specified or referred to in the Programme Memorandum of bLEND Funding Plc dated 8th August, 2018 (the Programme Memorandum) in respect of the Programme) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Programme Memorandum is not addressed.  Prior to relying on the information contained in the Programme Memorandum and/or the Supplement, you must ascertain from the Programme Memorandum whether or not you are part of the intended addressees of the information contained therein.

 

Your right to access the Supplement is conditional upon complying with the above requirement.

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
PSPLLFLTVEISLIA

a d v e r t i s e m e n t